Role of CXCL1 in tumorigenesis of melanoma

Journal of Leukocyte Biology

Volumn 72, Issue 1, 2002, Pages 9-18

  Dhawan, Punita ^a   Richmond, Ann ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokines; NF B; Signaling

Indexed keywords

ALPHA CHEMOKINE; CXCL1 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 2; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; BREAST TUMOR; CARCINOGENESIS; CELL TRANSFORMATION; COLON TUMOR; GENE EXPRESSION REGULATION; IMMUNOREGULATION; INFLAMMATION; MELANOMA; METASTASIS; OVARY TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY; TUMOR GROWTH; WOUND HEALING;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINES; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; GROWTH SUBSTANCES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOCYTES; MELANOMA; MICE; MODELS, IMMUNOLOGICAL; NF-KAPPA B; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

EID: 0036659130     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Baggiolini, M. (1998) Chemokines and leukocyte traffic. Nature 392, 565-568.
2. Schall, T. J., Bacon, K. B. (1994) Chemokines, leukocyte trafficking and inflammation. Curr. Opin. Immunol. 6, 865-873.
3. Cyster, J. G. (1999) Chemokines and cell migration in secondary lymphoid organs Science 286, 2098-2102.
4. Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., Strieter, R. M. (2000) CXC chemokines in angiogenesis. J. Leukoc. Biol. 68, 1-8.
5. Wang, J. M., Deng, X., Gong, W., Su, S. (1998) Chemokines and their role in tumor growth and metastasis. J. Immunol. Methods 220, 1-17.
6. Sallusto, F., Mackay, C. R., Lanzavecchia, A. (2000) The role of chemokine receptors in primary, effector, and memory immune responses Annu. Rev. Immunol. 18, 593-620.
7. Rossi, D., Zlotnik, A. (2000) The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-242.
8. Rollins, B. J. (1997) Chemokines. Blood 90, 909-928.
9. Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270, 27348-27357.
10. Yoneda, J., Kuniyasu, H., Crispens, M. A., Price, J. E., Bucana, C. D., Fidler, I. J. (1998) Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J. Natl. Cancer Inst. 90, 447-454.
11. Huang, M., Wang, J., Lee, P., Sharma, S., Mao, J. T., Meissner, H., Uyemura, K., Modlin, R., Wollman, J., Dubinett, S. M. (1995) Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res. 55, 3847-3853.
12. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., Strieter, R. M. (1996) Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184, 981-992.
13. Murdoch, C., Finn, A. (2000) Chemokine receptors and their role in inflammation and infectious diseases. Blood 95, 3032-3043.
14. Wells, T. N., Proudfoot, A. E. (1999) Chemokine receptors and their antagonists in allergic lung disease. Inflamm. Res. 48, 353-362.
15. Yamamoto, J., Adachi, Y., Onoue, Y., Kanegane, H., Miyawaki, T., Toyoda, M., Seki, T., Morohashi, M. (2000) CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis. Allergy 55, 1011-1018.
16. Mach, F. (2001) The role of chemokines in atherosclerosis. Curr. Atheroscler. Rep. 3, 243-251.
17. Tkachuk, A. N., Moormann, A. M., Poore, J. A., Rochford, R. A., Chensue, S. W., Mwapasa, V., Meshnick, S. R. (2001) Malaria enhances expression of CC chemokine receptor 5 on placental macrophages. J. Infect. Dis. 183, 967-972.
18. Loetscher, P., Moser, B., Baggiolini, M. (2000) Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv. Immunol. 74, 127-180.
19. International Union of Immunological Societies/World Health Organization Subcommittee on Chemokine Nomenclature (2001) Chemokine/chemokine receptor nomenclature. J. Leukoc. Biol. 70, 465-466.
20. Tang, T., Owen, J. D., Du, J., Walker, C. L., Richmond, A. (1998) Molecular cloning and characterization of a mouse gene with homology to the Duffy-antigen receptor for chemokines. DNA Seq. 9, 129-143.
21. Yang, Y. T., Chen, S. C., Leach, M. W., Manfra, D., Homey, B., Wiekowski, M., Sullivan, L., Jenh, C. H., Narula, S. K., Chensue, S. W., Lira, S. A. (2000) Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J. Exp. Med. 191, 445-454.
22. Rosenkilde, M. M., Waldhoer, M., Lüttichau, H. R., Schwartz, T. W., Rosenkilde, M. M. (2001) Virally encoded 7TM receptors. Oncogene 20, 1582-1593.
23. Strieter, R. M. (2001) Chemokines: not just leukocyte chemoattractants in the promotion of cancer. Nat. Immunol. 2, 285-286.
24. Gershengorn, M. C., Geras-Raaka, E., Varma, A., Clark-Lewis, I. (1998) Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J. Clin. Investig. 102, 1469-1472.
25. Arvanitakis, L., Geras-Raaka, E., Varma, A., Gershengorn, M. C., Cesarman, E. (1997) Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385, 347-350.
26. Burger, M., Burger, J. A., Hoch, R. C., Oades, Z., Takamori, H., Schraufstatter, I. U. (1999) Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor. J. Immunol. 163, 2017-2022.
27. Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E., Zlotnik, A. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56.
28. Mohle, R., Schittenhelm, M., Failenschmid, C., Bautz, F., Kratz-Albers, K., Serve, H., Brugger, W., Kanz, L. (2000) Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia. Br. J. Haematol. 110, 563-572.
29. Mohle, R., Failenschmid, C., Bautz, F., Kanz, L. (1999) Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1). Leukemia 13, 1954-1959.
30. Arai, J., Yasukawa, M., Yakushijin, Y., Miyazaki, T., Fujita, S. (2000) Stromal cells in lymph nodes attract B-lymphoma cells via production of stromal cell-derived factor-1. Eur. J. Haematol. 64, 323-332.
31. Koshiba, T., Hosotani, R., Miyamoto, Y., Ida, J., Tsuji, S., Nakajima, S., Kawaguchi, M., Kobayashi, H., Doi, R., Hori, T., Fujii, N., Imamura, M. (2000) Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin. Cancer Res. 6, 3530-3535.
32. Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., Balkwill, F. R. (2001) Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res. 61, 4961-4965.
33. Moser, B., Schumacher, C., von Tscharner, V., Clark-Lewis, I., Baggiolini, M. (1991) Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. J. Biol. Chem. 266, 10666-10671.
34. Schumacher, C., Clark-Lewis, I., Baggiolini, M., Moser, B. (1992) High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc. Natl. Acad. Sci. USA 89, 10542-10546.
35. Ahuja, S. K., Murphy, P. M. (1996) The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J. Biol. Chem. 271, 20545-20550.
36. Richmond, A., Thomas, H. G. (1988) Melanoma growth stimulatory activity: isolation from human melanoma tumors and characterization of tissue distribution. J. Cell. Biochem. 36, 185-198.
37. Bordoni, R., Fine, R., Murray, D., Richmond, A. (1990) Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes. J. Cell. Biochem. 44, 207-219.
38. Chenevix-Trench, G., Martin, N. G., Ellem, K. A. (1990) Gene expression in melanoma cell lines and cultured melanocytes: correlation between levels of c-src-1, c-myc and p53. Oncogene 5, 1187-1193.
39. Moser, B., Barella, L., Mattei, S., Schumacher, C., Boulay, F., Colombo, M. P., Baggiolini, M. (1993) Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem. J. 294, 285-292.
40. Rodeck, U., Melber, K., Kath, R., Menssen, H. D., Varello, M., Atkinson, B., Herlyn, M. (1991) Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J. Investig. Dermatol. 97, 20-26.
41. Norgauer, J., Metzner, B., Schraufstatter, I. (1996) Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. J. Immunol. 156, 1132-1137.
42. Devalaraja, R. M., Nanney, L. B., Du, J., Qian, Q., Yu, Y., Devalaraja, M. N., Richmond, A. (2000) Delayed wound healing in CXCR2 knockout mice. J. Investig. Dermatol. 115, 234-244.
43. Haghnegahdar, H., Du, J., Wang, D., Strieter, R. M., Burdick, M. D., Nanney, L. B., Cardwell, N., Luan, J., Shattuck-Brandt, R., Richmond, A. (2000) The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J. Leukoc. Biol. 67, 53-62.
44. Owen, J. D., Strieter, R., Burdick, M., Haghnegahdar, H., Nanney, L., Shattuck-Brandt, R., Richmond, A. (1997) Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. Int. J. Cancer 73, 94-103.
45. Balentien, E., Mufson, B. E., Shattuck, R. L., Derynck, R., Richmond, A. (1991) Effects of MGSA/GRO alpha on melanocyte transformation. Oncogene 6, 1115-1124.
46. Singh, R. K., Gutman, M., Radinsky, R., Bucana, C. D., Fidler, I. J. (1994) Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res. 54, 3242-3247.
47. Singh, R. K., Gutman, M., Reich, R., Bar-Eli, M. (1995) Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res. 55, 3669-3674.
48. Schadendorf, D., Moller, A., Algermissen, B., Worm, M., Sticherling, M., Czarnetzki, B. M. (1993) IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol. 151, 2667-2675.
49. Shelton, R. M. (2001) Skin cancer: a review and atlas for the medical provider. Mt. Sinai J. Med. 68, 243-252.
50. Anisowicz, A., Messineo, M., Lee, S. W., Sager, R. (1991) An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts. J. Immunol. 147, 520-527.
51. Shattuck, R. L., Wood, L. D., Jaffe, G. J., Richmond, A. (1994) MGSA/GRO transcription is differentially regulated in normal retinal pigment epithelial and melanoma cells. Mol. Cell. Biol. 14, 791-802.
52. Widmer, U., Manogue, K. R., Cerami, A., Sherry, B. (1993) Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and MIP-1 beta, members of the chemokine superfamily of proinflammatory cytokines. J. Immunol. 150, 4996-5012.
53. Ohmori, Y., Fukumoto, S., Hamilton, T. A. (1995) Two structurally distinct kappa B sequence motifs cooperatively control LPS-induced KC gene transcription in mouse macrophages. J. Immunol. 155, 3593-3600.
54. Marx, N., Mach, F., Sauty, A., Leung, J. H., Sarafi, M. N., Ransohoff. R. M., Libby, P., Plutzky, J., Luster, A. D. (2000) Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J. Immunol. 164, 6503-6508.
55. Wood, L. D., Richmond, A. (1995) Constitutive and cytokine-induced expression of the melanoma growth stimulatory activity/GRO alpha gene requires both NF-kappa B and novel constitutive factors. J. Biol. Chem. 270, 30619-30626.
56. Wood, L. D., Farmer, A. A., Richmond, A. (1995) HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene. Nucleic Acids Res. 23, 4210-4219.
57. Baldwin Jr., A. S. (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
58. Stancovski, I., Baltimore, D. (1997) NF-kappaB activation: the I kappaB kinase revealed? Cell 91, 299-302.
59. Karin, M. (1999) How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18, 6867-6874.
60. Regnier, C. H., Song, H. Y., Cao, Z., Rothe, M. (1997) Identification and characterization of an IkappaB kinase. Cell 90, 373-383.
61. DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., Karin, M. A. (1997) Cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388, 548-554.
62. Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., Karin, M. (1997) The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91, 243-252.
63. Israel, A. (2000) The IKK complex: an integrator of all signals that activate NF-kappaB? Trends Cell Biol. 10, 129-133.
64. Li, X. H., Fang, X., Gaynor, R. B. (2001) Role of IKKgamma/nemo in assembly of the Ikappa B kinase complex. J. Biol. Chem. 276, 4494-4500.
65. Malinin, N. L., Boldin, M. P., Kovalenko, A. V., Wallach, D. (1997) MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385, 540-544.
66. Woronicz, J. D., Gao, X., Cao, Z., Rothe, M., Goeddel, D. V. (1997) IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 278, 866-869.
67. Nakano, H., Shindo, M., Sakon, S., Nishinaka, S., Mihara, M., Yagita, H., Okumura, K. (1998) Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. USA 95, 3537-3542.
68. Nemoto, S., DiDonato, J. A., Lin, A. (1998) Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase. Mol. Cell. Biol. 18, 7336-7343.
69. Madrid, L. V., Wang, C. Y., Guttridge, D. C., Schottelius, A. J., Baldwin Jr., A. S., Mayo, M. W. (2000) Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol. Cell. Biol. 20, 1626-1638.
70. Sizemore, N., Leung, S., Stark, G. R. (1999) Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol. Cell. Biol. 19, 4798-4805.
71. Luan, J., Shattuck-Brandt, R., Haghnegahdar, H., Owen, J. D., Strieter, R., Burdick, M., Nirodi, C., Beauchamp, D., Johnson, K. N., Richmond, A. (1997) Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J. Leukoc. Biol. 62, 588-597.
72. Nirodi, C., NagDas, S., Gygi, S. P., Olson, G., Aebersold, R., Richmond, A. (2001) Role for poly (ADP-ribose) polymerase in the transcriptional regulation of the melanoma growth stimulatory activity (CXCL1) gene expression. J. Biol. Chem. 276, 9366-9374.
73. Lindahl, T. (1995) Recognition and processing of damaged DNA. J. Cell Sci. Suppl. 19, 73-77.
74. Berger, N. A. (1985) Poly(ADP-ribose) in the cellular response to DNA damage. Radiat. Res. 101, 4-15.
75. Lindahl, T., Satoh, M. S., Poirier, G. G., Klungland, A. (1995) Posttranslational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem. Sci. 20, 405-411.
76. Nirodi, C., Hart, J., Dhawan, P., Moon, N. S., Nepveu, A., Richmond, A. (2001) The role of CDP in the negative regulation of CXCL1 gene expression. J. Biol. Chem. 276, 26122-26131.
77. Blochlinger, K., Bodmer, R., Jack, J., Jan, L. Y., Jan, Y. N. (1988) Primary structure and expression of a product from cut, a locus involved in specifying sensory organ identity in Drosophila. Nature 333, 629-635.
78. Neufeld, E. J., Skalnik, D. G., Lievens, P. M., Orkin, S. H. (1992) Human CCAAT displacement protein is homologous to the Drosophila homeoprotein, cut. Nat. Genet. 1, 50-55.
79. Luo, W., Skalnik, D. G. (1996) Interferon regulatory factor-2 directs transcription from the gp91phox promoter. J. Biol. Chem. 271, 18203-18210.
80. Coqueret, O., Berube, G., Nepveu, A. (1998) The mammalian cut homeodomain protein functions as a cell-cycle-dependent transcriptional repressor which downmodulates p21WAF1/CIP1/SDI1 in S phase. EMBO J. 17, 4680-4694.
81. Van Gurp, M. F., Pratap, J., Luong, M., Javed, A., Hoffmann, H., Giordano, A., Stein, J. L., Neufeld, E. J., Lian, J. B., Stein, G. S., Van Wijnen, A. J. (1999) The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A. Cancer Res. 59, 5980-5988.
82. Kim, E. C., Lau, J. S., Rawlings, S., Lee, A. S. (1997) Positive and negative regulation of the human thymidine kinase promoter mediated by CCAAT binding transcription factors NF-Y/CBF, dbpA, and CDP/cut. Cell Growth Differ. 8, 1329-1338.
83. Miller, H., Asselin, C., Dufort, D., Yang, J. Q., Gupta, K., Marcu, K. B., Nepveu, A. (1989) A cis-acting element in the promoter region of the murine c-myc gene is necessary for transcriptional block. Mol. Cell. Biol. 9, 5340-5349.
84. Vanden Berghe, W., De Bosscher, K., Boone, E., Plaisance, S., Haegeman, G. (1999) The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J. Biol. Chem. 274, 32091-32098.
85. Li, S., Aufiero, B., Schiltz, R. L., Walsh, M. J. (2000) Regulation of the homeodomain CCAAT displacement/cut protein function by histone acetyltransferases p300/CREB-binding protein (CBP)-associated factor and CBP. Proc. Natl. Acad. Sci. USA 97, 7166-7171.
86. Li, S., Moy, L., Pittman, N., Shue, G., Aufiero, B., Neufeld, E. J., LeLeiko, N. S., Walsh, M. J. (1999) Transcriptional repression of the cystic fibrosis transmembrane conductance regulator gene, mediated by CCAAT displacement protein/cut homolog, is associated with histone deacetylation. J. Biol. Chem. 274, 7803-7815.
87. Shattuck-Brandt, R. L., Richmond, A. (1997) Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells. Cancer Res. 57, 3032-3039.
88. Yang, J., Richmond, A. (2001) Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells. Cancer Res. 61, 4901-4909.
89. Nasuhara, Y., Adcock, I. M., Catley, M., Barnes, P. J. (1999) Differential IkappaB kinase activation and IkappaBalpha degradation by interleukin-lbeta and tumor necrosis factor-alpha in human U937 monocytic cells. Evidence for additional regulatory steps in kappaB-dependent transcription. J. Biol. Chem. 274, 19965-19972.
90. Takaori-Kondo, A., Hori, T., Fukunaga, K., Morita, R., Kawamata, S., Uchiyama, T. (2000) Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling. Biochem. Biophys. Res. Commun. 272, 856-863.
91. Delhase, M., Hayakawa, M., Chen, Y., Karin, M. (1999) Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284, 309-313.
92. Matsushima, A., Kaisho, T., Rennert, P. D., Nakano, H., Kurosawa, K., Uchida, D., Takeda, K., Akira, S., Matsumoto. M. (2001) Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I. J. Exp. Med. 193, 631-636.
93. Lazar-Molnar, E., Hegyesi, H., Toth, S., Falus, A. (2000) Autocrine and paracrine regulation by cytokines and growth factors in melanoma Cytokine 12, 547-554.
94. Crespo, P., Leon, J. (2000) Ras proteins in the control of the cell cycle and cell differentiation. Cell Mol. Life Sci. 57, 1613-1636.
95. Mangues, R., Seidman, I., Gordon, J. W. Pellicer, A. (1992) Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice. Oncogene 7, 2073-2076.
96. Matsumoto, K., Asano, T., Endo, T. (1997) Novel small GTPase M-Ras participates in reorganization of actin cytoskeleton. Oncogene 15, 2409-2417.
97. Quilliam, L. A., Castro, A. F., Rogers-Graham, K. S., Martin, C. B., Der, C. J., Bi, C. (1999) M-Ras/R-Ras3, a transforming ras protein regulated by Sos1, GRF1, and p120 Ras GTPase-activating protein, interacts with the putative Ras effector AF6. J. Biol. Chem. 274, 23850-23857.
98. Lopez-Ilasaca, M., Crespo, P., Pellici, P. G., Gutkind, J. S., Wetzker, R. (1997) Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 275, 394-397.
99. Wang, D., Yang, W., Du, J., Devalaraja, M. N., Liang, P., Matsumoto, K., Tsubakimoto, K., Endo, T., Richmond, A. (2000) MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression. Oncogene 19, 4647-4659.
100. Bours, V., Bentires-Alj, M., Hellin, A. C., Viatour, P., Robe, P., Delhalle, S., Benoit, V., Merville, M. P. (2000) Nuclear factor-kappa B, cancer, and apoptosis. Biochem. Pharmacol. 60, 1085-1089.
101. Bellacosa, A., Franke, T. F., Gonzalez-Portal, M. E., Datta, K., Taguchi, T., Gardner, J., Cheng, J. Q., Testa, J. R., Tsichlis, P. N. (1993) Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications, Oncogene 8, 745-754.
102. Coffer, P. J., Jin, J., Woodgett, J. R. (1998) Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335, 1-13.
103. Toker, A., Newton, A. C. (2000) Cellular signaling: pivoting around PDK-1. Cell 103, 185-188.
104. Meier, R. Hemmings, B. A. (1999) Regulation of protein kinase. Recept. Signal Transduct. Res. 19, 121-128.
105. Datta, S. R., Brunet, A., Greenberg, M. E. (1999) Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927.
106. Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., Donner, D. B. (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85.
107. Romashkova, J. A., Makarov, S. S. (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling, Nature 401, 86-90.
108. Madrid, L. V., Wang, C. Y., Guttridge, D. C., Schottelius, A. J., Baldwin Jr., A. S., Mayo, M. W. (2000) Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB, Mol. Cell. Biol. 20, 1626-1638.
109. Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R., Tonks, N. K. (1997) P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase, Proc. Natl. Acad. Sci. USA 94, 9052-9057.
110. Li, J., Simpson, L., Takahashi, M., Miliaresis, C., Myers, M. P., Tonks, N., Parsons, R. (1998) The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res. 58, 5667-5672.
111. Guldberg, P., thor Straten, P., Birck, A., Ahrenkiel, V., Kirkin, A. F., Zeuthen, J. (1997) Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 57, 3660-3663.
112. Xiong, Y., Zhang, H., Beach, D. (1993) Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7, 1572-1583.
113. Sherr, C. J., Roberts, J. M. (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
114. Serrano, M., Gomez-Lahoz, E., DePinho, R. A., Beach, D., Bar-Sagi, D. (1995) Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 267, 249-252.
115. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., Bartek, J. (1995) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375, 503-506.
116. Sherr, C. J. (1998) Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984-2991.
117. Yang, J., Luan, J., Yu, Y., Li, C., DePinho, R. A., Chin, L., Richmond, A. (2001) Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. Cancer Res. 61, 8150-8157.
118. Elliott, P. J., Ross, J. S. (2001) The proteasome: a new target for novel drug therapies. Am. J. Clin. Pathol. 116, 637-646.
119. May, M. J., D'Acquisto, F., Madge, L. A., Glockner, J., Pober, J. S., Ghosh, S. (2000) Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289, 1550-1554.